Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice

Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice

Objective: to estimate the average duration of therapy with Avastin (bevacizumab) in patients with metastatic colorectal cancer (mCRC) in the daily clinical practice of cancer care facilities in Russia. Methods. The observational program is being implemented on the initiative of the Russian Medical...

Full description

Bibliographic Details
Main Authors: I V Poddubnaya, E V Bobrovskaya, L Yu Vladimirova, S S Gordeev, I S Davidenko, S A Emelyanov, O V Zharkova, I A Koroleva, S Yu Krasilnikova, S Ch Maikoparova, T A Malysheva, A A Modestov, A N Morozov, G B Stachenko, E A Strygina, E Kh Tlish, P S Feoktistova, A S Chichkanova, N Z Sherman
Format: Article
Language:Russian
Published: IP Habib O.N. 2013-03-01
Series:Современная онкология
Subjects:
metastatic colorectal cancer
targeted therapy
bevacizumab
Online Access:https://modernonco.orscience.ru/1815-1434/article/view/26877

Internet

https://modernonco.orscience.ru/1815-1434/article/view/26877

Similar Items